Iridex Reports Fourth Quarter and Full Year 2022 Financial Results
March 09, 2023 16:05 ET
|
IRIDEX Corporation
MOUNTAIN VIEW, Calif., March 09, 2023 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and...
Iridex to Present at the 35th Annual Roth Conference
March 07, 2023 16:05 ET
|
IRIDEX Corporation
MOUNTAIN VIEW, Calif., March 07, 2023 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and...
Iridex Introduces New Research and Showcases Five Events at the AGS Meeting
March 02, 2023 09:00 ET
|
IRIDEX Corporation
Five Events at Booth #5 Discover the latest surgical techniques and outcomes published by the International MicroPulse TLT Consensus Panel.Watch Dr. Syril Dorairaj’s e-poster on prospective...
Iridex to Report Fourth Quarter and Full Year 2022 Financial Results on March 9, 2023
February 23, 2023 16:05 ET
|
IRIDEX Corporation
MOUNTAIN VIEW, Calif., Feb. 23, 2023 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal...
Iridex Announces Preliminary Operational and Financial Results for Fourth Quarter and Full Year 2022
January 10, 2023 16:05 ET
|
IRIDEX Corporation
MOUNTAIN VIEW, Calif., Jan. 10, 2023 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal...
Iridex to Participate in Fireside Chat with Stifel Equity Research
December 06, 2022 17:07 ET
|
IRIDEX Corporation
MOUNTAIN VIEW, Calif., Dec. 06, 2022 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal...
Iridex Announces Record Third Quarter 2022 Financial Results
November 10, 2022 16:05 ET
|
IRIDEX Corporation
MOUNTAIN VIEW, Calif., Nov. 10, 2022 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal...
Iridex to Report Third Quarter 2022 Financial Results on November 10, 2022
October 27, 2022 16:05 ET
|
IRIDEX Corporation
MOUNTAIN VIEW, Calif., Oct. 27, 2022 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal...
Iridex Showcases its Non-Incisional Treatments for Glaucoma, Introduces Sweep Management Software, and Hosts 8 Physician Presentations at AAO 2022
September 29, 2022 16:05 ET
|
IRIDEX Corporation
MicroPulse® Transscleral Laser Therapy (TLT), continuous-wave transscleral cyclophotocoagulation (CW-TSCPC), and MicroPulse Laser Trabeculoplasty (MLT) are non-incisional treatments that expand ways...
Iridex to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase
August 18, 2022 16:05 ET
|
IRIDEX Corporation
MOUNTAIN VIEW, Calif., Aug. 18, 2022 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal...